Overview of indications and market price of cabozantinib in 2025

Cabozantinib is a targeted therapy drug that is a small molecule tyrosine kinase inhibitor. This drug is mainly used to treat various types of cancer, especially in areas such as renal cell carcinoma, hepatocellular carcinoma and thyroid cancer. Cabozantinib intervenes in the growth and spread of tumors by inhibiting multiple signaling pathways to achieve therapeutic purposes.

For renal cell carcinoma, cabozantinib is typically used in patients who have received prior anti-angiogenic therapy. The conditions of such patients are often complex. The use of cabozantinib can significantly delay the progression of tumors and improve the survival rate of patients. In addition, cabozantinib is also approved for the treatment of advanced hepatocellular carcinoma, especially in patients who have failed other treatments. Studies have shown that cabozantinib can effectively improve liver function and control the progression of the disease in these patients. In thyroid cancer, cabozantinib is mainly used to treat patients with advanced or metastatic thyroid cancer. These patients usually still have the risk of tumor progression after multiple treatments. Cabozantinib can effectively control tumor growth and improve the patient's quality of life. Cabozantinib's broad indications make it an important treatment option for many cancer patients.

As for the market price of cabozantinib, since the original drug is not marketed in China, patients often need to purchase it through overseas channels. Currently, on some online platforms, the common specifications of cabozantinib tablets include 20mg*30 tablets, 40mg*30 tablets and 60mg*30 tablets, etc. Each box sells for about 50,000 yuan. In international markets, such as Japan, Turkey and Europe, cabozantinib has been launched, usually in the form of tablets and capsules. The price of each box of tablets may be around 30,000 yuan, while the price of capsules may be as high as 40,000 yuan (the specific price is affected by exchange rate fluctuations).

In addition to the original drug, there are also a variety of generic drugs of cabozantinib in overseas markets. The efficacy of these generic drugs is basically the same as that of the original drug, and their prices are relatively low. For example, the price of generic drugs from Laos, Bangladesh and India may be less than RMB 100 for 20mg*90 tablets, which undoubtedly provides a more economical option for some patients.

Reference:https://en.wikipedia.org/wiki/Cabozantinib